NeuroOne appoints Jason Mills, Penumbra EVP of Strategy, to Board of Directors

NEUROONE MEDICAL TECHNOLOGIES Corp

Board size increased to five; Mills appointed as Class I director effective Dec 18, 2025.
Mills will serve on Compensation and Nominating & Corporate Governance Committees.
Mills is EVP of Strategy at Penumbra (PEN), a leading thrombectomy company.
Previously Managing Director and head of med-tech research at Canaccord Genuity for 13+ years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.